文献速递外周动脉疾病

孤立性腘动脉病变腔内治疗的疗效与安全性:网络Meta分析

Comparison of the Efficacy and Safety of Endovascular Treatment for Isolated Popliteal Lesions in Peripheral Artery Disease: A Network Meta-Analysis.
PubMed 文献 · Ann Vasc Surg · 2026-01-06

该网络Meta分析纳入11项研究共4179例患者,比较PTA、DCB、斑块旋切和支架治疗孤立性腘动脉病变的疗效与安全性。结果显示斑块旋切在降低1年全因死亡率和提高技术成功率方面有优势,支架在降低截肢风险方面更优,斑块旋切和支架的1年一期通畅率均显著优于PTA。

要点

  • 斑块旋切1年全因死亡率显著低于PTA和支架。
  • 支架1年大截肢和总截肢率显著优于PTA。
  • 斑块旋切和支架1年一期通畅率显著优于PTA。

核心结论

  • 斑块旋切在降低全因死亡率和提高技术成功率方面有优势,支架在降低截肢风险方面更优。
  • 斑块旋切和支架的1年一期通畅率均显著优于PTA。
  • DCB相比普通PTA疗效和安全性更优,但差异未达统计学显著性。

研究设计与样本

  • 网络Meta分析,系统检索Cochrane Library、Embase和PubMed数据库(2010-2025年)。
  • 纳入11项研究,共4179例患者。
  • 使用R软件进行网络Meta分析,比较PTA、DCB、斑块旋切和支架。

主要发现

  • 1年全因死亡率:斑块旋切显著低于PTA(OR=0.61,95%CI 0.41-0.87)和支架(OR=0.66,95%CI 0.44-0.97)。
  • 1年大截肢率和总截肢率:支架显著优于PTA(OR=0.64和0.65),斑块旋切、DCB与PTA无显著差异。
  • 1年一期通畅率:斑块旋切和支架显著优于PTA(OR=2.21和2.23)。
  • 技术成功率:斑块旋切显著高于其他3种干预。

临床怎么用

  • 对于孤立性腘动脉病变,斑块旋切可能降低死亡风险并提高技术成功率。
  • 支架可能降低截肢风险,斑块旋切和支架均可改善1年一期通畅率。
  • DCB相比普通PTA有更优趋势但未达统计学显著,需个体化选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study employed a network meta-analysis to systematically compare the efficacy and safety of different endovascular interventions for treating isolated popliteal lesions in peripheral arterial disease. METHODS: A systematic search was conducted across the Cochrane Library, Embase, and PubMed databases (2010-2025), identifying 11 studies involving 4,179 patients. A network meta-analysis was performed using R software to compare the efficacy of percutaneous transluminal angioplasty (PTA), drug-coated balloon (DCB), atherectomy, and stenting. Primary outcomes included all-cause mortality, major amputation rate, and overall amputation rate, while secondary outcomes comprised primary patency rate, freedom from target lesion revascularization, and technical success rate. RESULTS: In terms of 1-year all-cause mortality, atherectomy demonstrated significantly lower rates compared to both the PTA group (odds ratio [OR] = 0.61, 95% credible interval [CrI]: 0.41-0.87) and the stenting group (OR = 0.66, 95% CrI: 0.44-0.97). Regarding 1-year major amputation and overall amputation rates, stenting significantly outperformed PTA (OR = 0.64 and 0.65, respectively), while no significant differences were observed between atherectomy, DCB, and PTA groups. For 1-year primary patency rates, both atherectomy and stenting significantly outperformed PTA (OR = 2.21 and 2.23, respectively). Furthermore, the technical success rate of atherectomy was significantly higher than that of the other 3 interventions. CONCLUSION: Atherectomy demonstrates advantages in reducing all-cause mortality and improving technical success rates, while stenting yields superior outcomes in lowering amputation risk. Both atherectomy and stenting significantly outperform PTA in achieving 1-year primary patency rates. Although DCB demonstrates superior efficacy and safety compared with plain PTA, the differences did not reach statistical significance.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Mei F, Jiang P, Guan W, et al. Comparison of the Efficacy and Safety of Endovascular Treatment for Isolated Popliteal Lesions in Peripheral Artery Disease: A Network Meta-Analysis. Ann Vasc Surg. 2026. PMID: 41506343. doi:10.1016/j.avsg.2025.12.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。